Trials / Terminated
TerminatedNCT03566407
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Prometheus Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the relationship between noninvasive biomarkers (patient serological markers and metagenomic analysis of stool) and disease status as determined by colonoscopy and by clinical symptoms in patients with Crohn's disease, and to evaluate whether changes in the biomarker levels over time correlate to changes in the state of patients' disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Colonoscopy | Colonoscopy will be required for all subjects at 6 months - Visit 3. |
Timeline
- Start date
- 2018-05-04
- Primary completion
- 2019-03-29
- Completion
- 2019-03-29
- First posted
- 2018-06-25
- Last updated
- 2019-06-07
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03566407. Inclusion in this directory is not an endorsement.